CL King analyst Steven Marotta downgrades G-III Apparel Group (NASDAQ:GIII) from Buy to Neutral.
Why Is Gastrointestinal Disease Focused-RedHill Biopharma Stock Higher Over 100% Today?
The FDA has granted five years' market exclusivity for RedHill Biopharma Ltd's (NASDAQ: RDHL) Talicia under the Generating Antibiotic Incentives Now Act Qualified Infectious Disease Product designation, as recommended by the